Form 4 for EXEL EXELIXIS, INC.

Accepted 2023-12-04 00:00:00 ET · period of report 2023-11-30 · accession 0000939767-23-000120 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-12-04	2023-11-30+	EXEL	Hessekiel Jeffrey	EVP, GC, Sec	S - Sale	$22.04	-50.0K	558.3K	-8%	-$1.10M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-11-30	S	D	25,000	$22.01	583,345	D	—	—	(F2) Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. (F3) Includes 188,144 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
2	Common	Common Stock	2023-12-04	S	D	25,000	$22.06	558,345	D	—	—	(F4) Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.16. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. (F3) Includes 188,144 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.